We Help Companies Find New Sales Opportunities
Strakan has acquired Elfar, the Spanish pharmaceuticals distribution company with 45 staff, for undisclosed terms.
Strakan has raised £22m from investors to fund the expansion of its Borders-based pharmaceuticals business, and is interested in product and corporate acquisitions.
Strakan Pharmaceuticals is to merge with Proskelia of France, in order to create a combined skin, bone and hormone disorder company with a valuation of £200m.
Strakan Group has raised £30m in a private equity investment to fund the development of new drugs for bone and skin disease, and expects to create about 20 jobs at its Galashiels base.
Strakan Group, the Galashiels-based developer of prescription medicines, has received a £11m cash injection from a syndicate of investors and hopes to double the size of its 22-strong workforce over the next two years.